Science 37 welcomes David Coman as new CEO

– USA, CA –  Science 37, the industry leader in decentralized clinical trials, today announced that David Coman has joined the company as its CEO.…

Cardurion Pharmaceuticals announces Amy Schulman to its Board along with a private investment from Polaris Partners

– USA, MA –  Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced that it has consummated a private investment from Polaris Partners, a leading healthcare investment firm with a long history of partnering with entrepreneurs in biotechnology.…

Kymera Therapeutics appoints Dr Nello Mainolfi as CEO

– USA, MA –  Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to discover breakthrough therapies for patients, today announced Kymera Co-founder, President and Chief Scientific Officer Nello Mainolfi, PhD, has been promoted to President and CEO effective immediately.…